Cargando…

High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma

BACKGROUND: Serum levels of CA125 measured before any treatment have been evaluated in epithelial ovarian cancer (EOC) as a predictor of patient survival; however, results in survival index are controversial, as CA125 levels are influenced by several variables. Taking this into consideration, the pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morales-Vásquez, Flavia, Pedernera, Enrique, Reynaga-Obregón, Jesús, López-Basave, Horacio Noé, Gómora, María José, Carlón, Elisa, Cárdenas, Sandra, Silva-Ayala, Raúl, Almaraz, Miguel, Méndez, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936203/ https://www.ncbi.nlm.nih.gov/pubmed/27388275 http://dx.doi.org/10.1186/s13048-016-0247-6

Ejemplares similares

Simultaneous expression of steroid sulfatase and androgen receptor reduced overall survival of patients with epithelial ovarian tumors
por: Calvillo-Robledo, Argelia, et al.
Publicado: (2021)

Prognostic relevance of high pretreatment CA125 levels in primary serous ovarian cancer
por: Bachmann, Robert, et al.
Publicado: (2021)

Prognostic relevance of high pretreatment CA125 levels in primary serous ovarian cancer
por: Bachmann, Robert, et al.
Publicado: (2021)

Estrogen and androgen receptor expression in surface epithelium and inclusion cyst in the ovary of premenopausal and postmenopausal women
por: Mendez, Carmen, et al.
Publicado: (2013)

Expression of metalloproteinases MMP-2 and MMP-9 is associated to the presence of androgen receptor in epithelial ovarian tumors
por: Morales-Vásquez, Flavia, et al.
Publicado: (2020)

Sexual steroid hormone receptors profiles of ovarian carcinoma in Mexican women
por: Gómora, María J, et al.
Publicado: (2018)

Progesterone reduces cell survival in primary cultures of endometrioid ovarian cancer
por: Pedernera, Enrique, et al.
Publicado: (2019)

Nadir CA-125 level as prognosis indicator of high-grade serous ovarian cancer
por: Xu, Xia, et al.
Publicado: (2013)

Clinically Relevant Response to Treatment with Olaparib in a Patient with Refractory Multidrug-Resistant Ovarian Cancer and Central Nervous System Involvement: A Case Report
por: Vásquez, Flavia Morales, et al.
Publicado: (2020)

Androgen receptor is expressed in mouse cardiomyocytes at prenatal and early postnatal developmental stages
por: Pedernera, Enrique, et al.
Publicado: (2017)

Evaluation of serum CA125-Tn glycoform in peritoneal dissemination and surgical completeness of high-grade serous ovarian cancer
por: Jin, Xiayu, et al.
Publicado: (2022)

The prognostic value of pretreatment CA-125 levels and CA-125 normalization in ovarian clear cell carcinoma: a two-academic-institute study
por: Bai, Huimin, et al.
Publicado: (2016)

Targeting galectin-3 with a high-affinity antibody for inhibition of high-grade serous ovarian cancer and other MUC16/CA-125-expressing malignancies
por: Stasenko, Marina, et al.
Publicado: (2021)

Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer
por: Chen, Jie-Ping, et al.
Publicado: (2019)

CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer—A Multicenter Analysis
por: Wohlmuth, Christoph, et al.
Publicado: (2022)

Cell-free tumor DNA, CA125 and HE4 for the objective assessment of tumor burden in patients with advanced high-grade serous ovarian cancer
por: Heitz, Florian, et al.
Publicado: (2022)

The Significance of Normal Pretreatment Levels of CA125 (<35 U/mL) in Epithelial Ovarian Carcinoma
por: Menczer, Joseph, et al.
Publicado: (2015)

Efficacy of endocervical curettage and CA-125 measurement in endometrial serous carcinoma: A case series and literature review
por: İyibozkurt, Ahmet Cem, et al.
Publicado: (2015)

El posgrado en la Universidad de Guadalajara : procesos de formación - memorias de una gestión, 2001-2006
por: Reynaga Obregon, Sonia
Publicado: (2007)

Seis décadas en la formación de docentes para el campo
por: Reynaga Obregon, Sonia
Publicado: (1994)

Major complications following exenteration in cases of pelvic malignancy: an 18-year experience
por: Lopez-Basave, Horacio, et al.
Publicado: (2007)

Severe adenomyosis with unexpectedly high CA-125: report of a rare case
por: Abdelazim, Ibrahim A., et al.
Publicado: (2020)

GIST in a reference cancer center in México
por: López-Basave, Horacio Noe, et al.
Publicado: (2007)

Highly Sensitive Detection of CA 125 Protein with the Use of an n-Type Nanowire Biosensor
por: Malsagova, Kristina A., et al.
Publicado: (2020)

Preoperative CA125 Significantly Improves Risk Stratification in High-Grade Endometrial Cancer
por: Lombaers, Marike S., et al.
Publicado: (2023)

Interferon-γ signaling is associated with BRCA1 loss-of-function mutations in high grade serous ovarian cancer
por: Cardenas, Horacio, et al.
Publicado: (2019)

Peritoneal trauma releases CA125?
por: Redman, C. W., et al.
Publicado: (1988)

Exploring the Glycosylation of Serum CA125
por: Saldova, Radka, et al.
Publicado: (2013)

CA125 effects on humoral immunosuppression
por: Kline, J. Bradford, et al.
Publicado: (2017)

Influencia del derecho inglés en el sistema jurídico de Israel / José Noé Gómora Colín.
por: Gómora Colín, José Noé
Publicado: (2004)

Methods for Identification of CA125 from Ovarian Cancer Ascites by High Resolution Mass Spectrometry
por: Weiland, Florian, et al.
Publicado: (2012)

Oncological markers CA-125, CA 19-9 and endometriosis
por: Fiala, Ludek, et al.
Publicado: (2018)

Combination of serum CA19-9 and CA125 levels and contrast-enhanced ultrasound parametric data facilitates to differentiate ovarian serous carcinoma from ovarian malignant epithelial cancer
por: Zhang, Wei, et al.
Publicado: (2018)

High Frequency of PIK3CA Mutations in Low-Grade Serous Ovarian Carcinomas of Japanese Patients
por: Ishibashi, Tomoka, et al.
Publicado: (2019)

Serum Markers CA125, CA153, and CEA along with Inflammatory Cytokines in the Early Detection of Lung Cancer in High-Risk Populations
por: Li, Guangping, et al.
Publicado: (2022)

Serum CA125 and HE4 as Biomarkers for the Detection of Endometrial Cancer and Associated High-Risk Features
por: Barr, Chloe E., et al.
Publicado: (2022)

Massive Elevation of CA-125 in Chylous Ascites
por: Orbay, Tuğçe Merve, et al.
Publicado: (2023)

Phase I/Ib study of olaparib and carboplatin in heavily pretreated recurrent high-grade serous ovarian cancer at low genetic risk
por: Lampert, Erika J., et al.
Publicado: (2019)

High grade serous ovarian carcinomas originate in the fallopian tube
por: Labidi-Galy, S. Intidhar, et al.
Publicado: (2017)

Rising CA-125 (Cancer Antigen 125) Levels: Cancer Recurrence or a Vaccine Reaction?
por: Parkash, Jasmita, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4247vesphd0urveg671mdd9kvp